Prakiraan volume dodolan: Edwards Lifesciences Inc. (EW)

Logo korporat perusahaan Edwards Lifesciences Corporation (EW)

Edwards Lifesciences has achieved a breakthrough by developing minimally invasive heart valves that minimize trauma during surgery. The company's future sales trend reflects the market consensus on revenue, where the current parameter is 13.09. Stable demand is driven by an aging population and leadership in the B2B cardiac surgery segment. The non-cyclical nature of the business ensures resilient cash flows regardless of the global economic backdrop.

EW - Dodolan mangsa ngarep perusahaan Edwards Lifesciences Inc. ing rentang 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Edwards Lifesciences

Analisis umum perusahaan:Edwards Lifesciences Corporation EW
Produk merek Edwards Lifesciences Corp

Finding a balance between asset value and business quality requires analyzing the momentum of future inflows, which, through the kinetics of daily changes, allows one to filter out market noise and identify a genuine operational recovery. For Edwards Lifesciences (EW), such projected revenue reflects the resilience of the cardiology ecosystem, where clinic reliance on TAVR technologies converts into predictable growth in commercial metrics.

Pesaing langsung

Prakiraan pendapatan perusahaan Boston Scientific Corp (BSX)|Volume dodolan mangsa ngarep perusahaan ResMed RMD|Prakiraan pendapatan perusahaan Insulet Inc. PODD|Zimmer (ZBH) - Volume dodolan sing dikarepake perusahaan|CooperCompanies - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Align Technology, Inc.|GMED: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan TMDX|ATEC (Alphatec Corp) - Prakiraan volume dodolan|Artivion Inc (AORT) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan ENOV|Volume dodolan mangsa ngarep perusahaan Integra LifeSciences IART|Prakiraan volume dodolan ESTA (establishmentlabs.com)|Prakiraan volume dodolan Beta Bionics, Inc. BBNX|IRMD - Prakiraan pendapatan perusahaan|EMBC: Prakiraan pendapatan perusahaan|TNDM (Tandem Diabetes Care) - Volume dodolan mangsa ngarep perusahaan|AxoGen, Inc. - Pendapatan mangsa ngarep perusahaan|SIBN (SI-BONE Medical) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Orthofix Medical OFIX|Volume dodolan mangsa ngarep perusahaan BVS (Bioventus Inc)|OrthoPediatrics Inc. (KIDS) - Prakiraan dodolan perusahaan|Treace Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Strata Critical Medical Inc SRTA|Carlsmed, Inc. - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan RxSight Inc RXST|ClearPoint Neuro (CLPT) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan STXS (Stereotaxis Corporation)|Prakiraan pendapatan perusahaan neurostar.com|Volume dodolan mangsa ngarep perusahaan Sight Sciences, Inc. (SGHT)|Prakiraan volume dodolan OBIO|ANIK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan InspireMD, Inc. NSPR|ZJYL: Prakiraan pendapatan perusahaan|VANI: Volume dodolan mangsa ngarep perusahaan|Xtant Medical Holdings, Inc. - Prakiraan volume pendapatan perusahaan|NeuroOne Corp (NMTC) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Modular Med|Prakiraan pendapatan perusahaan myomo.com|Prakiraan pendapatan perusahaan COCH (Envoy Medical, Inc.)|Volume dodolan mangsa ngarep perusahaan VVOS (Vivos Therapeutics)|Prakiraan pendapatan perusahaan NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Volume dodolan mangsa ngarep perusahaan|Tenon Medical Inc. (TNON) - Volume dodolan sing dikarepake perusahaan|LFWD - Prakiraan pendapatan perusahaan|AMIX (Autonomix Medical) - Prakiraan pendapatan perusahaan|IVF: Prakiraan volume dodolan|BBLG (Bone Biologics) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Axonics Inc.|Volume dodolan sing dikarepake perusahaan Biolase, Inc. BIOL|Prakiraan pendapatan perusahaan Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan invobioscience.com INVO